BioNTech Recognizes Employees and Partners Including admedicum for Historic Vaccine

We take immense pride in being recognized by BioNTech SE for having been part of the unprecedented "project lightspeed" that eventually brought the first evidence-based and approved COVID-19 vaccine to the global population.


We applaud Professor Ugur Sahin, Dr. Özlem Türeci, and their entire great team for having made history in drug development. While our contribution is only microscopic, it is our company DNA to contribute with others to true progress for patients. This is why we look very much forward to this new year 2021!


Read more from BioNTech's press release


admedicum mentioned amongst BioNTech's Partners

Go back